Minaris Regenerative Medicine is a leading global contract development and manufacturing organization (CDMO) specializing in the production of cell and gene therapy products. With over 20 years of experience, we offer comprehensive clinical and commercial manufacturing services, development solutions, and cutting-edge technologies. Our state-of-the-art facilities in the United States, Europe, and Asia enable us to deliver life-changing therapies to patients worldwide.

At Minaris, we prioritize our client partnerships, catering to the specific needs and challenges of each individual organization. By providing expertise, strategic guidance, efficient workflows, and accessibility, we aim to be an extension of your in-house team, ensuring the highest level of quality and reliability. Our mission is to leverage our vast experience in global manufacturing services, development solutions, and technologies to enhance society's well-being.

In line with our name, derived from the Japanese word mirai meaning future and the English word miracle, we remain committed to pushing the boundaries of medicine and delivering miraculous results to the patients we serve. Join us in creating future cell therapy miracles and subscribe to our email list for the latest updates. Contact us today to embark on a transformative journey towards groundbreaking advancements in regenerative medicine